Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved TECENTRIQ ® (atezolizumab) for the treatment of people with metastatic non-small cell lung cancer ... Swiss Biotech, 1 month ago
FDA Approves Genetech's Cancer Immunotherapy Tecentriq® for People With A Specific Type of Metastatic Lung Cancer - PharmaVOICE, 1 month ago
Genentech???s Tecentriq Wins Second Approval of the Year, This Time for Lung Cancer - BioSpace, 1 month ago
2 images for "genentech rank"
Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon Asia's premier biopharmaceuticals company, Biocon ranks among the world's Top Ten Employers in Biotechnology, according to an annual survey conducted by Science/Science Careers ...HR In Asia, 1 month ago BIOCON : Ranked Among Global Top Ten Biotech Employers;The only Asian Company to Feature in 2016 Rankings 4 Traders, 1 month ago Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon, 1 month ago
Key Points Question Are the effects of a proposed trastuzumab biosimilar equivalent to those of trastuzumab in the treatment of ERBB2 (formerly HER2 or HER2/neu)positive metastatic breast cancer? Findings In this randomized clinical trial ...Journal of the American Medical Association, 3 days ago
A bill that would speed up approval for medications and medical devices shows how a major initiative can get traction This week, Congress is taking back up a sweeping bill introduced last year that would expand medical research funding while also ...Business Standard India, 3 days ago Business Standard - Would Washington's FDA Fix Cure the Patients or the Drug Industry? Friends of Cancer Research, 3 days ago
Focus magazine lists Formycon as growth champion 2017 - Biosimilar developer ranked first in the "Chemicals and Pharma" category - Ranked second among the top 500 companies in Germany by growth Munich - The biosimilar company Formycon has ...Wallstreet Online, 4 days ago FORMYCON : Focus magazine lists Formycon as growth champion 2017 4 Traders, 4 days ago
Epizyme, Inc. 's EPZM lead pipeline candidate, tazemetostat (an EZH2 inhibitor), has received Fast Track designation in the U.S. for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DCBL) whose tumors carry an ...Zacks.com, 5 days ago
More from: , Nasdaq...and 2 other sources
If I tell you someone is helpful, what image crosses your mind? Most people associate the word helpful with jobs like a crossing guard, or a traveler's aide at the airport. Helpful people are nice to be around, but they're rarely in charge, or so ...Huffington Post, 5 days ago
23rd November 2016 Birdwatchers are a strange lot. Who among us eagerly jumps out of bed at 4:30 am to stand motionless and silent in a frosty field, looking up into the clear blue sky, with a cramped neck and feet throbbing in cold with the vague ...Ecologist, 1 week ago
You are here Insights by Stanford Business › Warriors Owner Joe Lacob: A Relentless Pursuit of Excellence Leadership Written Warriors Owner Joe Lacob: A Relentless Pursuit of Excellence Lacob explains what it takes to turn around a ...Stanford GSB, 1 week ago
Johnson & Johnson 's JNJ subsidiary, Janssen, announced that the FDA has approved its immunotherapy Darzalex to be used in combination with standard-of-care Velcade (a proteasome inhibitor/PI) and dexamethasone or Revlimid (an immmunomodulatory ...Zacks.com, 1 week ago
on your WebpageAdd Widget >Get your members hooked!